BCL2 and non-Hodgkin lymphoma: For example, in non-Hodgkin’s lymphoma (NHL) and melanoma, a non-intuitive link between low expression of Bcl-2 and a high AI has been associated with increased mortality, suggesting that a high AI may be independently prognostic [81].